Perioperative cardiovascular care for patients undergoing noncardiac surgical intervention

JAMA Internal Medicine

Volumn 175, Issue 5, 2015, Pages 835-839

  Eagle, Kim A ^a   Vaishnava, Prashant ^a   Froehlich, James B ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

BETA ADRENERGIC RECEPTOR BLOCKING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIA; META ANALYSIS (TOPIC); MORBIDITY; NONCARDIAC SURGICAL INTERVENTION; PERIOPERATIVE PERIOD; PHYSIOLOGICAL PROCESS; PRACTICE GUIDELINE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SURGERY; TOTAL QUALITY MANAGEMENT; ADVERSE EFFECTS; CARDIOVASCULAR DISEASES; POSTOPERATIVE COMPLICATIONS; PROCEDURES; STANDARDS;

CARDIOVASCULAR DISEASES; HUMANS; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; QUALITY IMPROVEMENT; RISK ADJUSTMENT; SURGICAL PROCEDURES, OPERATIVE;

EID: 84929104604     PISSN: 21686106     EISSN: 21686114     Source Type: Journal    
DOI: 10.1001/jamainternmed.2015.0150     Document Type: Review

References (37)

1. Boucher CA, Brewster DC, Darling RC, Okada RD, Strauss HW, Pohost GM. Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery. N Engl J Med. 1985;312 (7):389-394.
2. Diamond GA, Forrester JS, Hirsch M, et al. Application of conditional probability analysis to the clinical diagnosis of coronary artery disease. J Clin Invest. 1980;65(5):1210-1221.
3. Eagle KA, Singer DE, Brewster DC, Darling RC, Mulley AG, Boucher CA. Dipyridamole-thallium scanning in patients undergoing vascular surgery: optimizing preoperative evaluation of cardiac risk. JAMA. 1987;257(16):2185-2189.
4. Eagle KA, Coley CM, Newell JB, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med. 1989;110(11):859-866.
5. Coley CM, Field TS, Abraham SA, Boucher CA, Eagle KA. Usefulness of dipyridamole-thallium scanning for preoperative evaluation of cardiac risk for nonvascular surgery. Am J Cardiol. 1992;69 (16):1280-1285.
6. Levinson JR, Boucher CA, Coley CM, Guiney TE, Strauss HW, Eagle KA. Usefulness of semiquantitative analysis of dipyridamole-thallium-201 redistribution for improving risk stratification before vascular surgery. Am J Cardiol. 1990;66(4):406-410.
7. Cambria RP, Brewster DC, Abbott WM, et al. The impact of selective use of dipyridamole-thallium scans and surgical factors on the current morbidity of aortic surgery. J Vasc Surg. 1992;15(1):43-50.
8. Dripps RD, Lamont A, Eckenhoff JE. The role of anesthesia in surgical mortality. JAMA. 1961;178: 261-266.
9. Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med. 1977;297(16): 845-850.
10. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100(10): 1043-1049.
11. Detsky AS, Abrams HB, McLaughlin JR, et al. Predicting cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med. 1986;1(4):211-219.
12. Eagle KA, Brundage BH, Chaitman BR, et al; Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery: report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 1996;93 (6):1278-1317.
13. Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014;64(22):e77-e137.
14. Thilen SR, Treggiari MM, Lange JM, Lowy E, Weaver EM, Wijeysundera DN. Preoperative consultations for Medicare patients undergoing cataract surgery. JAMA Intern Med. 2014;174(3): 380-388.
15. Eagle KA, Rihal CS, Mickel MC, Holmes DR, Foster ED, Gersh BJ; CASS Investigators; University of Michigan Heart Care Program. Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. Circulation. 1997;96(6):1882-1887.
16. Dawood MM, Gutpa DK, Southern J, Walia A, Atkinson JB, Eagle KA. Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention. Int J Cardiol. 1996;57(1):37-44.
17. McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med. 2004;351(27): 2795-2804.
18. Froehlich JB, Karavite D, Russman PL, et al; American College of Cardiology; American Heart Association. American College of Cardiology/American Heart Association preoperative assessment guidelines reduce resource utilization before aortic surgery. J Vasc Surg. 2002;36(4): 758-763.
19. Neuman MD, Bosk CL, Fleisher LA. Learning from mistakes in clinical practice guidelines: the case of perioperative β-blockade. BMJ Qual Saf. 2014;23(11):957-964.
20. Soumerai SB, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA. 1997;277(2):115-121.
21. Krumholz HM, Radford MJ, Wang Y, Chen J, Heiat A, Marciniak TA. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA. 1998;280(7):623-629.
22. Mangano DT, Layug EL, Wallace A, Tateo I; Multicenter Study of Perioperative Ischemia Research Group. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med. 1996;335(23):1713-1720.
23. Leung JM. Diabetes and not lack of treatment with atenolol predicts decreased survival after noncardiac surgery. Anesthesiology. 1999;90(4): 1226-1227.
24. American College of Physicians. Guidelines for assessing and managing the perioperative risk from coronary artery disease associated with major noncardiac surgery. Ann Intern Med. 1997;127(4): 309-312.
25. Poldermans D, Boersma E, Bax JJ, et al; Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med. 1999; 341(24):1789-1794.
26. Eagle KA, Berger PB, Calkins H, et al; American College of Cardiology; American Heart Association. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol. 2002;39(3): 542-553.
27. Devereaux PJ, Beattie WS, Choi PT, et al. How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? systematic review and meta-analysis of randomised controlled trials. BMJ. 2005;331(7512):313-321.
28. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005;353(4): 349-361.
29. Brady AR, Gibbs JS, Greenhalgh RM, Powell JT, Sydes MR; POBBLE Trial Investigators. Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg. 2005;41(4):602-609.
30. Juul AB, Wetterslev J, Gluud C, et al; DIPOM Trial Group. Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ. 2006; 332(7556):1482.
31. Yang H, Raymer K, Butler R, Parlow J, Roberts R. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J. 2006;152(5):983-990.
32. Devereaux PJ, Yang H, Yusuf S, et al; POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371(9627):1839-1847.
33. Fleisher LA, Beckman JA, Brown KA, et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation. 2009;120(21): e169-e276.
34. Erasmus Medical Centre. Report on the 2012 follow-up investigation of possible breaches of academic integrity. http://cardiobrief.files.wordpress.com/2012/10/integrity-report-2012-10-english-translation.pdf. Published April 17, 2012. Accessed September 19, 2014.
35. Bouri S, Shun-Shin MJ, Cole GD, Mayet J, Francis DP. Meta-analysis of secure randomised controlled trials of β-blockade to prevent perioperative death in non-cardiac surgery. Heart. 2014;100(6):456-464.
36. Husten L. New perspective on the Dutch cardiovascular research scandal. http://cardiobrief.org/2012/04/17/new-perspective-on-the-dutch-cardiovascular-research-scandal/. Published April 17, 2012. Accessed November 18, 2014.
37. Kotecha D, Holmes J, Krum H, et al; Beta-Blockers in Heart Failure Collaborative Group. Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. Lancet. 2014;384(9961):2235-2243.